Funding
Seed · Biotech

Ferrosa Therapeutics raises $3.5m seed round from Forty51 Ventures

The financing backs development of a bispecific antibody for anemia of inflammation.

Updated Oct 16, 2026By RoundOS Funding desk

Ferrosa Therapeutics raised $3.5 million in seed financing from Forty51 Ventures on April 23. The company develops a bispecific antibody intended to treat anemia of inflammation.

Funding history

Seed · This round$3.5M

Sources

  1. Ferrosa Therapeuticsprojectstartups.com
  2. prnewswire.com

Similar rounds

All Biotech rounds →
Guoke Brain-Computer

Beijing startup developing non-invasive wearable brain-computer interfaces that combine brain-signal detection, decoding and neural modulation.

UndisclosedSeed · Oct 23, 2026
Star Therapeutics

Biotechnology company discovering and developing antibody therapies for diseases with significant unmet need.

$200MPrivate financing · Oct 23, 2026
Pathos AI

Clinical-stage drug developer using AI to select therapeutic assets and guide oncology trials.

$237MSeries E · Oct 23, 2026
Warp Sciences

Warp Sciences combines chemistry, AI and robotics to help drug discovery teams make and test molecules in the United States.

$215MSeries A · Oct 22, 2026

Related